SCHEDULE 13G/A: Kent Lake Entities Report Full Divestment of Neuronetics, Inc. Shares
Beneficial Ownership Update
Kent Lake PR LLC, Kent Lake Partners LP, and Benjamin Natter have filed an amended Schedule 13G, indicating they no longer hold any beneficial ownership in Neuronetics, Inc. as of December 31, 2024.
Summary
- Kent Lake PR LLC, Kent Lake Partners LP, and Benjamin Natter (collectively, 'Reporting Persons') have filed an Amendment No. 1 to their Schedule 13G regarding their beneficial ownership of Common Stock ($0.01 par value) in Neuronetics, Inc.
- The filing indicates that as of December 31, 2024, the Reporting Persons collectively hold 0.00 shares, representing 0.0% of the class of Neuronetics, Inc. Common Stock.
- This amendment suggests a complete divestment or reduction below the 5% reporting threshold by these entities, who previously held a reportable stake in the company.
- The filing was made under Rule 13d-1(b), which applies to institutional investors who acquire more than 5% of a company's stock in the ordinary course of business without the intent to influence control.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative as the filing indicates a complete divestment by previously significant beneficial owners, which can be viewed as a loss of investor confidence.
Negatives
- The filing indicates that Kent Lake PR LLC, Kent Lake Partners LP, and Benjamin Natter, who previously held a reportable stake in Neuronetics, Inc., now report 0% beneficial ownership, implying a full divestment of their holdings.
Future Outlook
This document does not contain any forward-looking statements or guidance regarding Neuronetics, Inc.'s future performance or operations.
Industry Context
This filing is a standard regulatory disclosure of changes in beneficial ownership by institutional investors. The divestment by Kent Lake entities could be interpreted by the market as a change in investor sentiment towards Neuronetics, Inc., potentially influencing other investors' perceptions.
Stakeholder Impact
- Shareholders: The divestment by a significant investor could lead to negative market sentiment and potentially impact the stock price.
- Company Management: May need to address investor concerns or questions regarding the reasons for the divestment by these entities.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (reporting period end date). |
| 02/14/2025 | Signature date of the Schedule 13G/A filing by Benjamin Natter on behalf of the Reporting Persons. |
Keywords
Neuronetics Inc., SEC filing, Schedule 13G/A, beneficial ownership, institutional investor, divestment, stock ownership, NNRX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.